Article
Phosphoprotein-based biomarkers as predictors for cancer therapy
20 Jul 2020
Abstract excerpt
Disparities in cancer patient responses have prompted widespread searches to identify differences in sensitive vs. nonsensitive populations and form the basis of personalized medicine. This customized approach is dependent upon the development of pathway-specific therapeutics in conjunction with biomarkers that predict patient responses. Here, we show that Cdk5 drives growth in subgroups of patients with multiple...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
